OR WAIT null SECS
© 2022 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Schulman IRB will launch its new Central Oncology Review (COR) division this month.
Schulman IRB will launch its new Central Oncology Review (COR) division this month. The COR will feature a roster of oncology industry leaders, academics and distinguished scientists, each with a background in managing specialized oncology research.
Read the full release here